Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Current understanding of the epidemiology mechanisms, and prevention of dental caries in preschool children.
2003
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Dental plaque as a biofilm and a microbial community – implications for health and disease
2006
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Bell's Palsy Associated with Linezolid Therapy: Case Report and Review of Neuropathic Adverse Events
2006
Linezolid-Associated Peripheral Neuropathy
2004
Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens
2008
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence
2006
Molecular mechanisms of antibiotic resistance
2014 Standout
The case for maternal vaccination against pertussis
2007
Prospects for the development of probiotics and prebiotics for oral applications
2009
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
2013
Healthy Children With Invasive Community-acquired Methicillin-resistant Staphylococcus aureus Infections
2006
Clustering of subgingival microbial species in adolescents with’ periodontitis
2011
Microbiologic Characteristics and In Vitro Susceptibility to Antimicrobials in a Large Population of Patients with Cardiovascular Implantable Electronic Device Infection
2011
Quantification of Subgingival Bacterial Pathogens at Different Stages of Periodontal Diseases
2012
Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials
2008
Linezolid versus vancomycin for skin and soft tissue infections
2013
Community-acquired methicillin-resistant Staphylococcus aureus infections
2006
Mechanism and Regulation of NLRP3 Inflammasome Activation
2016 Standout
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
2007
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Community-associated meticillin-resistant Staphylococcus aureus
2010
Medical treatment overview
2011
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
2013
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case–control study
2004
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
2004
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
2008
Oral multispecies biofilm development and the key role of cell–cell distance
2010 Standout
The oxazolidinones: past, present, and future
2011
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
2005
Ceftaroline
2009
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
2006
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Linezolid for the treatment of adults with bone and joint infections
2007
Linezolid Therapy for Orthopedic Infections
2004
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
2012
LINEZOLID-RESISTANT STAPHYLOCOCCUS AUREUS IN TWO PEDIATRIC PATIENTS RECEIVING LOW-DOSE LINEZOLID THERAPY
2006
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
2005
Treatment of bacterial skin and skin structure infections
2003
Quinupristin‐Dalfopristin and Linezolid: Evidence and Opinion
2003
Tannerella forsythia, a periodontal pathogen entering the genomic era
2006
Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections
2005
Microbial interactions: from networks to models
2012 Standout
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures
2008
Linezolid in the treatment of Gram-positive prosthetic joint infections
2005
Autism
2013 Standout
The Microflora of the Erupting First Permanent Molar
2004
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good
2011
Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
2013
Acute Osteomyelitis in Children
2014
Dental caries
2007 Standout
Periodontitis: a polymicrobial disruption of host homeostasis
2010 Standout
Streptococcus gordonii utilizes several distinct gene functions to recruit Porphyromonas gingivalis into a mixed community
2006
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Update on linezolid: the first oxazolidinone antibiotic
2005
Indigenous Microflora and Innate Immunity of the Head and Neck
2007
Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites
2010
Successful Treatment of Chronic Bone and Joint Infections with Oral Linezolid
2004
Clinical management of Staphylococcus aureus bacteraemia
2011
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*
2010
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections
2009
Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program
2003
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
2009
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
The human skin microbiome
2018 Standout
Silver nanoparticles as a new generation of antimicrobials
2008 Standout
Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infections in Children
2006
Do we really need new anti-infective drugs?
2003
The human microbiome: at the interface of health and disease
2012 Standout
Complementary and Alternative Medicine in Autism: An Evidence-Based Approach to Negotiating Safe and Efficacious Interventions with Families
2010
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Plazomicin: A Next‐Generation Aminoglycoside
2018
Linezolid Therapy for Orthopedic Infections
2004
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Gut Microbiota in Health and Disease
2010 Standout
Subgingival Microbiome Shifts and Community Dynamics in Periodontal Diseases
2016
LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus
2010
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
Mode of Delivery and Other Maternal Factors Influence the Acquisition of Streptococcus mutans in Infants
2005
Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
2003
A Toll-Like Receptor 2-Responsive Lipid Effector Pathway Protects Mammals against Skin Infections with Gram-Positive Bacteria
2005 StandoutNobel
The Caries Microbiome: Implications for Reversing Dysbiosis
2018
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Linezolid versus vancomycin for skin and soft tissue infections
2016
Engineering microbial consortia: a new frontier in synthetic biology
2008 StandoutNobel
Investigational treatments for postoperative surgical site infections
2007
Similarity of Bacterial Populations in Saliva from African-American Mother-Child Dyads
2007
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Acquisition and Transmission of Mutans Streptococci
2003
Bacterial, behavioral and environmental factors associated with early childhood caries
2003
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Role of microbial communities in the pathogenesis of periodontal diseases and caries
2017
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
2005
Prosthetic Joint Infection
2014 Standout
Are dental diseases examples of ecological catastrophes?
2003 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The oral microbiota: dynamic communities and host interactions
2018 Standout
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
2008 StandoutNobel
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Guidelines for the Prevention and Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus: A Perspective for Canadian Health Care Practitioners
2006
Industry sponsorship and research outcome
2017 Standout
Association of mutans streptococci between caregivers and their children.
2008
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa
2007
Works of Jon Bruss being referenced
Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
2011
Dental caries and its relationship to bacterial infection, hypoplasia, diet, and oral hygiene in 6‐ to 36‐month‐old children
2000
A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder
2009
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogens
2003
Linezolid for the treatment of complicated skin and skin structure infections in children
2003
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children
2003
Similarity of the oral microbiota of pre‐school children with that of their caregivers in a population‐based study
2002
Safety and tolerability of linezolid in children
2003
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid
2003
Hematologic effects of linezolid in young children
2003
Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates
2003
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children
2003
Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin
1999
Periodontal pathogen detection in gingiva/tooth and tongue flora samples from 18‐ to 48‐month‐old children and periodontal status of their mothers
2002
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children
2003
The Microbiota of Young Children from Tooth and Tongue Samples
2002
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
2001
Hematologic Effects of Linezolid: Summary of Clinical Experience
2002